P-Cresol

P-Cresol

SCHEMBL6986663

CCOC(=O)C(C)Oc1ccc(C)cc1.Cc1ccc(O)cc1

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.61
L3MBTL1 Q9Y468 1/20 0.61
KMT2A Q03164 4/20 0.55
ALDH2 P05091 1/20 0.53
MEN1 O00255 2/20 0.48
EPHX2 P34913 2/20 0.47
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
ESR1 P03372 1/20 0.46
CA7 P43166 1/20 0.46
CA9 Q16790 1/20 0.46
ESR2 Q92731 1/20 0.46
CA14 Q9ULX7 1/20 0.46
MAPT P10636 4/20 0.44
TRPM8 Q7Z2W7 1/20 0.43
ALDH1A1 P00352 3/20 0.43
TSHR P16473 2/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9621303 0.95 LMNA (0.66) LMNAL3MBTL1KMT2AALDH2MEN1
SCHEMBL5789381 0.95 LMNA (0.66) LMNAL3MBTL1KMT2AALDH2MEN1
SCHEMBL2481397 0.95 LMNA (0.66) LMNAL3MBTL1KMT2AALDH2MEN1
SCHEMBL18562096 0.93 LMNA (0.63) LMNAL3MBTL1KMT2AALDH2MEN1
SCHEMBL5205374 0.93 LMNA (0.63) LMNAL3MBTL1KMT2AALDH2MEN1
SCHEMBL9857703 0.83 LMNA (0.63) LMNAL3MBTL1KMT2AALDH2MEN1
SCHEMBL9063261 0.83 LMNA (0.63) LMNAL3MBTL1KMT2AALDH2MEN1
SCHEMBL11548487 0.83 L3MBTL1 (0.63) LMNAL3MBTL1KMT2AALDH2MEN1
SCHEMBL10430413 0.83 LMNA (0.52) LMNAL3MBTL1KMT2AALDH2MEN1
SCHEMBL10387518 0.82 TSHR (0.53) LMNAL3MBTL1KMT2AALDH2ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1313717-A1 OXAZOLYL-ARYLPROPIONIC ACID DERIVATIVES AND THEIR USE AS PPAR AGONISTS ELI LILLY AND COMPANY (US) 2003-05-28 EP disclosed
WO-2002016332-A1 OXAZOLYL-ARYLPROPIONIC ACID DERIVATIVES AND THEIR USE AS PPAR AGONISTS ELI LILLY AND COMPANY (US) 2002-02-28 WO disclosed